Copyright
©The Author(s) 2024.
World J Gastrointest Oncol. Mar 15, 2024; 16(3): 761-772
Published online Mar 15, 2024. doi: 10.4251/wjgo.v16.i3.761
Published online Mar 15, 2024. doi: 10.4251/wjgo.v16.i3.761
Characteristics | 2010-2014, 154 patients | 2015-2019, 174 patients | All patients, 328 |
Sex, n (%) | |||
Male | 122 (79) | 133 (76) | 255 (78) |
Female | 32 (21) | 41 (24) | 73 (22) |
Age in yr, mean ± SD | |||
At diagnosis | 67.6 ± 11.8 | 70 ± 10.7 | 68.9 ± 11.3 |
At death | 69.7 ± 12.2a | 72.4 ± 10.5a | 71 ± 11.4 |
Etiology, n (%) | |||
HCV | 65 (42) | 70 (40) | 135 (41) |
HBV | 10 (6) | 5 (3) | 15 (5) |
Alcoholic | 18 (12) | 40 (23) | 58 (18) |
Multiple etiology1 | 16 (10) | 20 (11) | 36 (11) |
NAFLD | 5 (3) | 2 (1) | 7 (2) |
Hereditary hemochromatosis | 0 (0) | 4 (2) | 4 (1) |
Unknown/idiopathic | 40 (26) | 33 (19) | 73 (22) |
- Citation: Bracco C, Gallarate M, Badinella Martini M, Magnino C, D'Agnano S, Canta R, Racca G, Melchio R, Serraino C, Polla Mattiot V, Gollè G, Fenoglio L. Epidemiology, therapy and outcome of hepatocellular carcinoma between 2010 and 2019 in Piedmont, Italy. World J Gastrointest Oncol 2024; 16(3): 761-772
- URL: https://www.wjgnet.com/1948-5204/full/v16/i3/761.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v16.i3.761